Guideline implementation is effective at reducing proton pump inhibitor use in hematology-oncology units: A multidisciplinary intervention for reducing Clostridioides difficile risk. (30th August 2019)

• Record Type: Journal Article
• Authors: Ziegler, Matthew J.; Freyer, Craig; Landsburg, Daniel; Pegues, David; Bilker, Warren; Hirsh, Rebecca; Kucharczuk, Colleen; Gilmar, Cheryl; Gorman, Theresa; Palmer, Melissa; Harker, Christina; Lightheart, Erin; Han, Jennifer H.
• Is Part Of: Infection control and hospital epidemiology. Volume 40:Number 11(2019)
• Page Start: 1294
• Page End: 1296
• Publication Date: 2019-08-30
• Subjects: Nosocomial infections -- Epidemiology -- Periodicals; Health facilities -- Sanitation -- Periodicals; Hospital buildings -- Sanitation -- Periodicals; Cross Infection -- Periodicals; Epidemiology -- Periodicals; Hospitals -- Periodicals; Infection Control -- Periodicals; 614.44
• DOI: 10.1017/ice.2019.238
• Languages: English
• ISSNs: 0899-823X

Abstract

Abstract: We implemented a guideline for appropriate acid suppressant use in hematology-oncology patients. This intervention resulted in a sustained reduction in proton pump inhibitor (PPI) use without an increase in rates of gastrointestinal bleeding. Practice guidelines are effective in reducing PPI use, which is associated with risk of Clostridioides difficile infection.